KR890014745A - Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물 - Google Patents

Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물 Download PDF

Info

Publication number
KR890014745A
KR890014745A KR1019890002870A KR890002870A KR890014745A KR 890014745 A KR890014745 A KR 890014745A KR 1019890002870 A KR1019890002870 A KR 1019890002870A KR 890002870 A KR890002870 A KR 890002870A KR 890014745 A KR890014745 A KR 890014745A
Authority
KR
South Korea
Prior art keywords
compound
reaction
pharmaceutical composition
δppm
chloroform
Prior art date
Application number
KR1019890002870A
Other languages
English (en)
Inventor
고조 오찌
마사미 에자끼
모리따 이와미
다다아끼 고모리
마사노부 고사까
Original Assignee
후지사와 도모기지로오
후지사와 약구힝고교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 도모기지로오, 후지사와 약구힝고교 가부시끼가이샤 filed Critical 후지사와 도모기지로오
Publication of KR890014745A publication Critical patent/KR890014745A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/085—Bacillus cereus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus
    • Y10S435/834—Bacillus cereus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

내용 없음.

Description

FR-900493화합물과 그 제조방법 및 그를 함유한 의약조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1도는 KBr에서 FR-900493화합물의 적외선 흡수스펙트럼이며,
제 2도는 D2O에서 FR-900493화합물의1H핵자기공명스펙트럼이며,
제 3도는 D2O에서 FR-900493화합물의13C핵자기공명스펙트럼이다.

Claims (8)

  1. 다음의 물리량 및 화학량을 가지는 FR-900493화합물
    (1) 외관 : 백색분말
    (2) 성질 : 양성
    (3) 용융짐 : 157-160℃(dec).
    (4) 광활성도 :: +27°(c 1.0, H2O)
    (5) 분자식 : C20H33N5O11,
    (6) 성분분석 : C20H33N5O112H2O에 대해 계산 : c 43.23, H 6.71, N 12.61(%)
    발견 C43.34, H 6.56, N 12.68(%)
    (9) 분자량 : SI-MS : m/z 520 ()+1)
    (8) 용해성 : 용해 ; 물, 비용해 ; 메탄올, 아세톤, 에틴아세데이트, 클로로포름.
    (7) 색반응 : 양성 ; 닌히드린, 요호드, 황산세륨 및 과망간산칼륨 각각과의 반응, 몰리시반응, 음성 ; 염화철 및 디아세틸제 각각과의 반응.
    (10) 박층크로마토그래피 : 정상상태 ; 실리카겔(키에셀겔 60 F-254, Merck제), 현상용매 ; n-부탄올 : 에탄올 : 클로로포름 : 28% 수성암모니아=4 : 7 : 2 : 7 v/v, Rf값 : 0.10.
    (11)
    (12) IR(KBr) : ν최대 : 3650-2200(br), 1670, 1620, 1570, 1555, 1540, 1500, 1495, 1390, 1350, 1340, 1270, 1240, 1170, 1100, 1050, 1000, 950, 920, 860, 820, 780cm-1.
    (13)1H NMR(D2O) : δppm ; 1.70∼2.00 (2H, m), 2.41 (3H, s). 2.44-2.68 (1H. m), 2.70-2.92 (1H, m), 3.00-3.31 (4H, m), 3.50 (1H, d. J=8Hz), 4.05-4.34 (8H, m), 5.21 (1H, br s), 5.75 (1H, d, J=2Hz), 5.82 (1H, d, J=8Hz), 7.79 (1H, d, J=8Hz).
    (14)13C NMR (D2O) δppm , 175.7. 171.3, 155.2, 141.9, 110.1, 102.4, 91.4. 83.7, 80.7, 78.5, 75.4, 74.2, 71,4, 71.3, 69.9, 52.3, 41.8, 39.0. 38.7, 25.0.
  2. 제 1항에 있어서, 영양물질내에서 바실루스종에 속하는 FR-900493화합물 생성균주를 배양한후 FR-900493화합물을 회복시키는 것으로 구성된 FR-900493화합물을 제조하는 방법.
  3. 제 1항에 있어서, 약제에 적합하고 본질적으로 비독성인 담체 또는 부형제에 활성성분으로 FR-900493화합물을 조합한 의약조성물.
  4. 제 1항에 있어서, FR-900493화합물을 약물로써 사용하는 방법.
  5. 제 1항에 있어서, FR-900493화합물을 항미생물제로써 사용하는 방법.
  6. 제 1항에 있어서, FR-900493화합물을 전염병치료 또는 예방약 제조에 사용하는 방법.
  7. 인간 또는 동물에게 FR-900493화합물을 주사하는 것으로 구성된 전염병치료 또는 예방방법.
  8. 미생물 바실루스 세레우스 No.2045(FERM BP-1791)의 생물학적 순수배양법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890002870A 1988-03-18 1989-03-09 Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물 KR890014745A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888806429A GB8806429D0 (en) 1988-03-18 1988-03-18 Fr-900493 substance process for production & pharmaceutical composition containing same
GB8806429 1988-03-18

Publications (1)

Publication Number Publication Date
KR890014745A true KR890014745A (ko) 1989-10-25

Family

ID=10633652

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890002870A KR890014745A (ko) 1988-03-18 1989-03-09 Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물

Country Status (5)

Country Link
US (1) US4950605A (ko)
EP (1) EP0333177A3 (ko)
JP (1) JPH01296992A (ko)
KR (1) KR890014745A (ko)
GB (1) GB8806429D0 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19844469A1 (de) * 1998-09-28 2000-03-30 Herzog Mesmer Artur Antimikrobielle Mittel, Verfahren zu deren Herstellung und deren Verwendung
WO2007064985A2 (en) * 2005-12-02 2007-06-07 Terra Preta, Llc Methods and compositions for improving plant growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
JPS61134398A (ja) * 1984-12-06 1986-06-21 Microbial Chem Res Found 新生理活性物質プリパスタチン及びその製造法

Also Published As

Publication number Publication date
EP0333177A3 (en) 1990-04-04
US4950605A (en) 1990-08-21
JPH01296992A (ja) 1989-11-30
GB8806429D0 (en) 1988-04-20
EP0333177A2 (en) 1989-09-20

Similar Documents

Publication Publication Date Title
JP2997545B2 (ja) 化粧用脱臭剤
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
GR3026218T3 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
CA2044746A1 (en) Polypeptide compound and a process for preparation thereof
DE59009074D1 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus.
DE69815750D1 (de) Verfahren zur Herstellung von Ascorbinsäurederivaten
HUP9802861A2 (hu) Calendula glikozidok alkalmazása bőrsejtek túlburjánzásával kapcsolatos betegségek, így psoriasis kezelésére alkalmas gyógyászati készítmény előállítására, ezen vegyületek, valamint ezeket tartalmazó gyógyászati készítmények
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
HUP0001741A2 (hu) Antibakteriális hatású aza-biciklo-karbamoil-oxi-mutilin-származékok, eljárás ezek előállítására, ezeket tartalmazó készítmények és alkalmazásuk
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
AU3453493A (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR890014745A (ko) Fr-900493화합물과 그 제조방법 및 그를 함유한 의약조성물
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
DE69512419D1 (de) IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
AP9801235A0 (en) Erythromycin derivatives.
OA09665A (fr) Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
KR880009943A (ko) 피리다지논 유도체
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
JPS5655397A (en) Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative
IE790857L (en) Amino group-containing derivatives of 3-alkyl-5-(2-¹hydroxystyryl)-isoxazoles

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid